michigan glp-1 nausea class action Expert Q&A: Medicaid's new limits on weight management medications Frontiers | Psychiatric adverse events

Semaglutide and tirzepatide are only approved for the treatment of a certain number of conditions: obesity and overweight, type 2 diabetes, sleep apnea, and cardiovascular disease

Were trying to make it as communal living as we can do it

This chronic caloric excess eventually overwhelms the storage capacity of visceral adipose tissue, leading to adipose tissue failure

What you eat beforehand, what you drink afterward, even your body position during administration, all of these factors determine whether 10% or 40% of the active compound actually reaches your bloodstream

Weight loss is just a side effect of these medications